Advertisement

Opioid News

February 21, 2017
February 21, 2017
At the start of 2017, FDA approved two new abuse-deterrent opioids. Morphine sulfate (Arymo—Egalet) extended-release (ER) was given agency approval...
Experts are split on whether opioids with abuse-deterrent properties are the best answer to the prescription opioid abuse epidemic
MORE
January 03, 2017
January 03, 2017
FDA Center for Drug and Evaluation and Research Director Janet Woodcock, MD, joined the agency’s December 20, 2016, podcast to discuss the agency’s...
Opioid Action Plan initiatives include approval of warning label language and Medication Guides, potential addition of IR opioids to REMS program
MORE
December 21, 2016
December 21, 2016
On December 20, DEA released a notice that clarifies DEA’s renewal process. The December 20 notice is a welcome change for pharmacists because DEA’s...
DEA will maintain grace periods and other policies regarding registration renewals
MORE
December 19, 2016
December 19, 2016
CDC has released new tools and materials to give health care providers more resources to help curb prescription opioid abuse and overdose. Two of...
App and educational videos are among new resources
MORE
December 16, 2016
December 16, 2016
DEA has released a notice that could have serious implications for pharmacists, prescribers, researchers, manufacturers, distributors, and others...
DEA will end grace periods and adopt tougher policies to renew controlled substance registrations
MORE
December 13, 2016
Our country is facing a crisis around substance misuse.  According to Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs,...
MORE
November 17, 2016
November 17, 2016
A first-ever Surgeon General’s Report on Alcohol, Drugs, and Health launched on November 17 gives health care providers, policy makers, law...
Report on alcohol, drugs, and health released today
MORE
November 14, 2016
November 14, 2016
Pharmacists in New Mexico were some of the first in the nation to prescribe naloxone—an antidote for opioid overdose. Naloxone is covered under...
State laws vary, but pharmacists can be integral to naloxone access
MORE
October 24, 2016
October 24, 2016
CDC has released a brochure targeting pharmacists as key to fighting the opioid abuse epidemic and preventing overdoses. Pharmacists: On the Front...
Brochure offers tips on working with prescribers and communicating with patients who may be at risk
MORE
September 13, 2016
September 13, 2016
With the number of cancer survivors increasing—almost 14 million in the United States—the prevalence of those patients experiencing pain has been...
New guidelines promote use of both nonpharmacologic and pharmacologic treatments
MORE

Pages